文献速递创伤与烧伤心脑血管急症

创伤性脑损伤中血小板抑制与功能障碍的快速检测:一项前瞻性观察研究

Rapid detection of platelet inhibition and dysfunction in traumatic brain injury: A prospective observational study.
PubMed 文献 · J Trauma Acute Care Surg · 2022-01-01
一句话结论在孤立性创伤性颅内出血患者中,快速血小板功能检测普遍显示血小板反应不良,但与临床结局无关,且血小板输注未改善结局。

本研究前瞻性纳入2018至2020年221例孤立性创伤性颅内出血患者,在到达创伤抢救室时及6小时后用VerifyNow和全血聚集法(WBA)检测血小板功能。无抗血小板药物患者中,VerifyNow和WBA分别有29.7%和67.7%显示血小板反应不良;阿司匹林患者分别为72.2%和82.2%;氯吡格雷患者分别为67.9%和88.9%。血小板无反应组与反应组在院内死亡率、tICH进展、ICU入住率和住院时间上均无显著差异。血小板输注未改善血小板反应或患者结局。

要点

  • 在孤立性tICH患者中,无论是否使用抗血小板药物,快速血小板功能检测均常见血小板反应不良(无药者WBA 67.7%)。
  • 血小板无反应组与反应组的院内死亡率(3.0% vs 6.3%,p=0.324)和tICH进展(27.1% vs 26.1%,p=0.877)无显著差异。
  • 血小板输注未改善血小板反应或患者结局。
  • VerifyNow与全血聚集法在tICH患者中相关性一般。
  • 快速血小板功能检测结果不应单独用于指导tICH患者的血小板输注决策。

适用人群与场景

  • 2018至2020年前瞻性纳入的孤立性创伤性颅内出血(tICH)患者,共221例;包括未用抗血小板药111例、阿司匹林78例、氯吡格雷6例、阿司匹林联合氯吡格雷26例。
  • 场景为到达创伤抢救室时及6小时后检测血小板功能。

诊断标准与关键阈值

  • 血小板功能检测方法为VerifyNow和全血聚集法(WBA);血小板反应不良的定义原文未提及具体界值。

处置流程与药物剂量

  • 到达创伤抢救室时及6小时后分别进行VerifyNow和WBA检测血小板功能。
  • 原文未提及基于检测结果的具体处置流程或药物剂量。
  • 血小板输注未改善血小板反应或患者结局。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型为前瞻性观察研究,样本量221例,单中心(原文未明确中心数,但为单中心研究设计),人群为孤立性tICH患者。
  • 无抗血小板药物患者中,VerifyNow和WBA分别有29.7%和67.7%显示血小板反应不良;阿司匹林患者分别为72.2%和82.2%;氯吡格雷患者分别为67.9%和88.9%。
  • 血小板无反应组与反应组院内死亡率(3 [3.0%] vs 6 [6.3%],p=0.324)、tICH进展(26 [27.1%] vs 24 [26.1%],p=0.877)、ICU入住率(34 [34.3%] vs 38 [40.0%],p=0.415)、住院时间(3 [IQR 2-8] vs 3.2 [IQR 2-7],p=0.818)均无显著差异。
  • 血小板输注未改善血小板反应或患者结局。
  • VerifyNow与WBA在tICH患者中相关性一般。

证据类型、等级与局限

  • 证据类型为前瞻性观察研究(诊断性试验),证据等级为Level II(诊断测试)。
  • 局限:单中心、观察性设计、样本量221例、未提及盲法、血小板反应不良定义未明确界值。

对床旁实践的改变

  • 快速血小板功能检测可识别tICH患者中高比例的血小板反应不良,但检测结果与临床结局无关,不应单独据此决定血小板输注。
  • 血小板输注可能不改善tICH患者的临床结局,需谨慎使用。
  • 适用人群为孤立性tICH患者;不适用于其他类型创伤或非tICH人群。
  • 常见陷阱:将血小板功能检测异常等同于需要血小板输注,而原文显示输注未改善结局。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

BACKGROUND: Rapid platelet function testing is frequently used to determine platelet function in patients with traumatic intracranial hemorrhage (tICH). Accuracy and clinical significance of decreased platelet response detected by these tests is not well understood. We sought to determine whether VerifyNow and whole blood aggregometry (WBA) can detect poor platelet response and to elucidate its clinical significance for tICH patients.

METHODS: We prospectively enrolled patients with isolated tICH between 2018 and 2020. Demographics, medical history, injury characteristics, and patient outcomes were recorded. Platelet function was determined by VerifyNow and WBA testing at the time of arrival to the trauma bay and 6 hours later.

RESULTS: A total of 221 patients were enrolled, including 111 patients on no antiplatelet medication, 78 on aspirin, 6 on clopidogrel, and 26 on aspirin and clopidogrel. In the trauma bay, 29.7% and 67.7% of patients on no antiplatelet medication had poor platelet response on VerifyNow and WBA, respectively. Among patients on aspirin, 72.2% and 82.2% had platelet dysfunction on VerifyNow and WBA. Among patients on clopidogrel, 67.9% and 88.9% had platelet dysfunction on VerifyNow and WBA. Patients with nonresponsive platelets had similar in-hospital mortality (3 [3.0%] vs. 6 [6.3%], p = 0.324), tICH progression (26 [27.1%] vs. 24 [26.1%], p = 0.877), intensive care unit admission rates (34 [34.3%] vs. 38 [40.0%), p = 0.415), and length of stay (3 [interquartile range, 2-8] vs. 3.2 [interquartile range, 2-7], p = 0.818) to those with responsive platelets. Platelet transfusion did not improve platelet response or patient outcomes.

CONCLUSION: Rapid platelet function testing detects a highly prevalent poor platelet response among patients with tICH, irrespective of antiplatelet medication use. VerifyNow correlated fairly with whole blood aggregometry among patients with tICH and platelet responsiveness detectable by these tests did not correlate with clinical outcomes. In addition, our results suggest that platelet transfusion may not improve clinical outcomes in patients with tICH.

LEVEL OF EVIDENCE: Diagnostic tests, level II.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Alvikas J, Zenati M, Campwala I, et al. Rapid detection of platelet inhibition and dysfunction in traumatic brain injury: A prospective observational study. J Trauma Acute Care Surg. 2022. PMID: 34629458. doi:10.1097/TA.0000000000003427

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。